In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

The Ohio mother and former teacher used her final months to write lessons for her sons and to help others living with ...

When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, ...

When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, ...

Jamie-Lynn Sigler has been living with Multiple Sclerosis for over two decades, a chronic illness that significantly impacts her daily life. Her diagnosis, which she revealed publicly in 2016, ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).

Exclusive: Sigler, who has MS, spoke to 'The Independent' ahead of her guest role on 'Grey's Anatomy,' where she plays a ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Jamie-Lynn Sigler praises Eric Dane’s ALS role ahead of her own Grey’s Anatomy MS storyline - Exclusive: Sigler, who has MS, ...